Li Cao
- Molecular Biology
- Cancer Research top 10%
- Rheumatology top 10%
- Epidemiology
- Pharmacology top 10%
- Topics
- Osteoarthritis Treatment and Mechanisms (11 papers)Inflammatory mediators and NSAID effects (6 papers)Chemokine receptors and signaling (4 papers)
- Journals
- PLoS ONEOncogeneScientific Reports
- Partner nations
- ChinaUnited States
In The Last Decade
Li Cao
25 papers receiving 533 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 258
- Cancer Research 167
- Rheumatology 152
- Epidemiology 111
- Pharmacology 91
Countries citing papers authored by Li Cao
This map shows the geographic impact of Li Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Cao more than expected).
Fields of papers citing papers by Li Cao
This network shows the impact of papers produced by Li Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Cao. The network helps show where Li Cao may publish in the future.
Co-authorship network of co-authors of Li Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Cao. A scholar is included among the top collaborators of Li Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Cao. Li Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 28 | |
| 10 | 30 | |
| 11 | 54 | |
| 12 | 17 | |
| 13 | 36 | |
| 14 | 14 | |
| 15 | 11 | |
| 16 | 9 | |
| 17 | 2 | |
| 18 | 25 | |
| 19 | 172 | |
| 20 | 47 |
About Li Cao
Li Cao is a scholar working on Rheumatology, Pharmacology and Immunology, having authored 27 papers that have together received 539 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (11 papers), Inflammatory mediators and NSAID effects (6 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Cancer Research (167 citations), Rheumatology (152 citations) and Pharmacology (91 citations). Li Cao has collaborated with scholars based in China and United States. Frequent co-authors include Daolin Tang, Yan Yu, Lei Yang, Ming Zhao, Philip Vernon, R Kang, Shan Zhu, Baochao Ji, Wenbo Mu and Boyong Xu. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.